DKT International and Shanghai Dahua Pharmaceutical (Dahua) have entered into a strategic partnership to expand the availability, accessibility, and affordability of Levoplant. Manufactured by Dahua, Levoplant is a two-rod contraceptive implant that provides protection from pregnancy for three years and has been pre-qualified by the World Health Organization. As the global marketing partner, DKT will be responsible for introducing Levoplant into new markets, fulfilling purchase orders, developing educational and promotional materials, and servicing customer needs. In announcing the partnership, DKT and Dahua noted that Levoplant will be offered at a price of $6.90 per unit in FP2020 focus countries.
For more information, contact True Overholt at DKT International at true@dktinternational.org.
Comments